{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:56:30Z","timestamp":1760266590166},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.mehy.2005.02.036","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T11:41:32Z","timestamp":1114602092000},"page":"591-594","source":"Crossref","is-referenced-by-count":7,"title":["Do vasoactive neuropeptide autoimmune disorders explain pyridostigmine\u2019s association with Gulf War syndrome?"],"prefix":"10.1016","volume":"65","author":[{"given":"Donald","family":"Staines","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5\u201310","key":"10.1016\/j.mehy.2005.02.036_bib1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1191\/0748233701th120oa","article-title":"Evaluation of immunotoxicity induced by single or concurrent exposure to N,N-diethyl-m-toluamide (DEET), pyridostigmine bromide (PYR), and JP-8 jet fuel","volume":"17","author":"Peden-Adam","year":"2001","journal-title":"Toxicol Ind Health"},{"issue":"11","key":"10.1016\/j.mehy.2005.02.036_bib2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/milmed\/163.11.725","article-title":"Self-reported chemical sensitivity and wartime chemical exposures in Gulf War veterans with and without decreased global health ratings","volume":"163","author":"Bell","year":"1998","journal-title":"Mil Med"},{"issue":"12","key":"10.1016\/j.mehy.2005.02.036_bib3","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/oem.2003.009258","article-title":"Symptoms and medical conditions in Australian veterans of the 1991 Gulf War: relation to immunisations and other Gulf War exposures","volume":"61","author":"Kelsall","year":"2004","journal-title":"Occup Environ Med"},{"issue":"5","key":"10.1016\/j.mehy.2005.02.036_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.1991.03470050093029","article-title":"Pyridostigmine used as a nerve agent pre-treatment under wartime conditions","volume":"266","author":"Keeler","year":"1991","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.mehy.2005.02.036_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.mehy.2004.02.008","article-title":"Overview of an autoimmune theory of vasoactive neuropeptides in the aetiology of certain conditions","volume":"62","author":"Staines","year":"2004","journal-title":"Med Hypotheses"},{"issue":"3","key":"10.1016\/j.mehy.2005.02.036_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.mehy.2004.08.013","article-title":"Do vasoactive neuropeptides and heat shock proteins mediate fatigue-related autoimmune disorders","volume":"64","author":"Staines","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2005.02.036_bib7","doi-asserted-by":"crossref","unstructured":"Staines DR. Do cytosine guanine dinucleotide (CpG) fragments induce vasoactive neuropeptide mediated fatigue-related autoimmune disorders? Med Hypotheses, in press, doi:10.1016\/j.mehy.2005.02.014","DOI":"10.1016\/j.mehy.2005.02.014"},{"issue":"1","key":"10.1016\/j.mehy.2005.02.036_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mehy.2005.02.013","article-title":"Are vasoactive neuropeptide autoimmune fatigue-related disorders mediated via G protein-coupled receptors?","volume":"65","author":"Staines","year":"2005","journal-title":"Med Hypotheses"},{"issue":"12","key":"10.1016\/j.mehy.2005.02.036_bib9","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00043764-200112000-00006","article-title":"Self-reported exposures and their association with unexplained illness in a population-based case-control study of Gulf War veterans","volume":"43","author":"Spencer","year":"2001","journal-title":"J Occup Environ Med"},{"issue":"2-3","key":"10.1016\/j.mehy.2005.02.036_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0091-3057(01)00596-2","article-title":"The combined effects of pyridostigmine and chronic stress on brain cortical and blood acetylcholinesterase, corticosterone, prolactin and alternation performance in rats","volume":"70","author":"Kant","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.mehy.2005.02.036_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1006\/nbdi.2002.0524","article-title":"Disruption of the blood\u2013brain barrier and neuronal cell death in cingulate cortex, dentate gyrus, thalamus and hypothalamus in a rat model of Gulf-War syndrome","volume":"10","author":"Abdel-Rahman","year":"2002","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.mehy.2005.02.036_bib12","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1124\/jpet.102.044818","article-title":"Delayed neurologic and behavioural effects of subtoxic doses of cholinesterase inhibitors","volume":"304","author":"Scremin","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.mehy.2005.02.036_bib13","first-page":"150","article-title":"Persistent\/delayed toxic effects of low-dose sarin and pyridostigmine under physical stress (exercise) in mice","volume":"48","author":"Husain","year":"2004","journal-title":"Indian J Physiol Pharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2005.02.036_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jat.765","article-title":"Interaction of pyridostigmine and physical stress on antioxidant defence system in skeletal muscle of mice","volume":"21","author":"Jagannathan","year":"2001","journal-title":"J Appl Toxicol"},{"issue":"4","key":"10.1016\/j.mehy.2005.02.036_bib15","first-page":"541","article-title":"Muscarinic receptor-mediated pyridostigmine-induced neuronal apoptosis","volume":"21","author":"Li","year":"2000","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.mehy.2005.02.036_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-4274(01)00380-0","article-title":"Combined exposure to sarin and pyridostigmine bromide increased levels of rat urinary 3-nitrosine and 8-hydroxy-2\u2032-deoxyguanosine, biomarkers of oxidative stress","volume":"123","author":"Abu-Qare","year":"2001","journal-title":"Toxicol Lett"},{"issue":"6","key":"10.1016\/j.mehy.2005.02.036_bib17","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/(SICI)1097-4598(199906)22:6<696::AID-MUS5>3.0.CO;2-Q","article-title":"Effects of exposure to low-dose pyridostigmine on neuromuscular junctions in vitro","volume":"22","author":"Drake-Baumann","year":"1999","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.mehy.2005.02.036_bib18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1152\/japplphysiol.00736.2004","article-title":"Activation of the vasoactive intestinal peptide 2 receptor modulates normal and atrophying skeletal muscle mass and force","volume":"98","author":"Hinkle","year":"2005","journal-title":"J Appl Physiol"},{"issue":"4","key":"10.1016\/j.mehy.2005.02.036_bib19","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.4049\/jimmunol.162.4.2103","article-title":"Functional expression of receptors for calcitonin gene-related peptide, calcitonin and vasoactive intestinal peptide in the human thymus and thymomas from myasthenic gravis patients","volume":"162","author":"Marie","year":"1999","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2005.02.036_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/IPH-120029939","article-title":"Pyridostigmine bromide (PYR) alters immune function in B6C3F1 mice","volume":"26","author":"Peden-Adams","year":"2004","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"1\u20133","key":"10.1016\/j.mehy.2005.02.036_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0300-483X(02)00421-3","article-title":"Pyridostigmine bromide modulates topical irritant-induced cytokine release from human epidermal keratinocytes and isolated perfused porcine skin","volume":"183","author":"Monteiro-Riviere","year":"2003","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.mehy.2005.02.036_bib22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1210\/jc.78.3.763","article-title":"Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man","volume":"78","author":"Trasforini","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mehy.2005.02.036_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0960-5428(96)00007-1","article-title":"Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs","volume":"6","author":"Ganea","year":"1996","journal-title":"Adv Neuroimmunol"},{"key":"10.1016\/j.mehy.2005.02.036_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2000.tb06950.x","article-title":"Vasoactive intestinal peptide (VIP) receptor type 2 (VPAC2) is the predominant receptor expressed in human thymocytes","volume":"921","author":"Lara-Marquez","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.mehy.2005.02.036_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1096\/fasebj.12.1.119","article-title":"Vasoactive intestinal peptide enhancement of antigen-induced differentiation of a cultured line of mouse thymocytes","volume":"12","author":"Pankhaniya","year":"1998","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.mehy.2005.02.036_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0041-008X(88)90368-7","article-title":"Segmental depression caused by diisopropylphosphorofluoridate and sarin is reversed by thyrotropin-releasing hormone in the neonatal rat spinal cord","volume":"95","author":"Das Gupta","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2005.02.036_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0891-0618(97)10002-3","article-title":"Association between pituitary adenylate cyclase-activating polypeptide and thyrotropin-releasing hormone in the rat hypothalamus","volume":"13","author":"Legradi","year":"1997","journal-title":"J Chem Neuroanat"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987705001453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987705001453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T01:52:00Z","timestamp":1683078720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987705001453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0306987705001453"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2005.02.036","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}